|
|
||||||||
1 Channing Laboratory, Brigham & Women's Hospital, Boston, MA, USA. 2 University Hospital, Groningen, The Netherlands
CORRESPONDENCE: S.T. Weiss, 181 Longwood Avenue, Channing Laboratory, Boston, MA 02115, USA. Fax: 1 6175252745. E-mail: Scott.weiss@channing.harvard.edu
Keywords: airway hyperresponsiveness, comorbidities, exacerbation, pulmonary function testing, outcome measurement
Received: August 21, 2002
Accepted February 20, 2003
Chronic obstructive pulmonary disease (COPD) is the most rapidly rising cause of death in individuals >65 yrs of age, the most rapidly growing segment of the USA population.
Advancing the clinical research agenda for COPD entails careful consideration of several issues and problems: defining COPD, reliance on physiological testing, outcome measurements and comorbidities.
In addition, issues pertaining to the recent dramatic increase in chronic obstructive pulmonary disease mortality in females, smoking susceptibility and the relationship of respiratory symptoms with hyperresponsiveness, as well as chronic obstructive pulmonary disease heterogeneity, are discussed.
This article has been cited by other articles:
![]() |
A. Caballero, C. A. Torres-Duque, C. Jaramillo, F. Bolivar, F. Sanabria, P. Osorio, C. Orduz, D. P. Guevara, and D. Maldonado Prevalence of COPD in Five Colombian Cities Situated at Low, Medium, and High Altitude (PREPOCOL Study) Chest, February 1, 2008; 133(2): 343 - 349. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |